New technique alleviates painful bone metastases

A targeted beam of energy directed at painful sites can cause relief within days, according to findings from Fox Chase Cancer Center

2013-05-31

(Press-News.org) CHICAGO, IL (May 29, 2013)—A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3.

During the procedure, known as MR-guided focused ultrasound, doctors direct a concentrated beam of energy to specific nerve endings that are causing pain in bone metastases. These patients typically have a significant amount of discomfort—half of study participants rated their pain at least a 7 out of 10—but within a handful of days, most said they felt significant relief.

Although Fox Chase patients received local anesthesia during the procedure, the most commonly reported side effect was pain—which can often be alleviated with additional anesthesia, says study author Joshua Meyer, MD, attending physician in the Radiation Oncology Department at Fox Chase. "That's temporary pain, which is gone as soon as the procedure is over," he says. "The whole reason we're doing the procedure is for the pain relief that comes afterwards. And that's relatively quick—we see a response by a day or so, and within three days of the procedure most patients are reporting a significant improvement."

Specifically, 67% of the 107 treated patients said their pain was "much improved" after the treatment, and that relief continued through the end of the three-month study. In comparison, among a group of 35 patients that received a "sham" treatment—they entered the machine but did not receive the intervention—only 20% reported some pain relief, Meyer and his colleagues reported.

During the procedure, patients enter into an MRI machine, which allows clinicians to direct a cone of ultrasound energy at specific, targeted bone sites that are causing pain. The MRI also acts as a thermometer to measure the temperature deep within the body created by the high dose of energy, which generates enough heat to burn the nerve endings that are causing pain.

Although pain relief was durable until the end of the study at 90 days, it's not clear how much longer the pain relief lasts, says Meyer. "We've had reports of patients experiencing pain relief up to a year or more outside of the study."

Typically, patients with bone metastases are treated with radiation, which shrinks the bone cancer that is putting pressure on nerve endings, causing pain. This technique also treats the cancer (MR-guided focused ultrasound may not), but often takes weeks before patients experience pain relief, and not all will respond, says Meyer. In addition, others may not be eligible to receive additional radiation, if they have limited bone marrow function, for instance, he notes. The latest research didn't compare the effectiveness of the ultrasound technique to radiation, but the response to ultrasound appears "within the same ballpark of that in previous studies with radiation."

MR-guided focused ultrasound has been approved by the U.S. Food and Drug Administration, and is available at Fox Chase Cancer Center, as well as a handful of other facilities around the country.

### Co-authors on the study include Mark Hurwitz, MD, Pejman Ghanouni, MD, and Suzanne LeBlang, MD.

Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute's prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center's nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427) or visit http://www.foxchase.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Researchers narrow the search for biomarkers of drug resistance in head and neck cancer patients

2013-05-31

CHICAGO, IL (May 29, 2013)—Researchers from Fox Chase Cancer Center will present data at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1, which shows the discovery of potential biomarkers that may be used to identify patients with head and neck cancer whose tumors are unlikely to respond to treatment by the targeted therapy cetuximab—a type of monoclonal antibody. The FDA approved the drug, in combination with radiation or as a second-line drug after chemotherapy had failed, in 2006. In 2011, the drug was approved as a first-line ...

Researchers investigate a less toxic radiation treatment for HPV-Positive oropharynx cancer

2013-05-31

CHICAGO, IL (May 29, 2013)—Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, ...

New therapy is tolerable in lung cancer

2013-05-31

CHICAGO, IL (May 28, 2013)—A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1. "We're very excited about this drug," says Hossein Borghaei, DO, chief of thoracic medical oncology at Fox Chase. "I think if we learn how ...

Many solid tumors carry genetic changes targeted by existing compounds

2013-05-31

CHICAGO, IL (May 28, 2013)—Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3. The results suggest that it may one day become commonplace for doctors to sequence tumors before deciding on a treatment regimen. "Extended sequencing of a patient's tumor is not something that's routinely done now," says study author Patrick Boland, ...

Bright light therapy may improve sleep and promote recovery in patients with mild TBI

2013-05-31

DARIEN, IL – A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI). Results show that six weeks of morning bright light therapy resulted in a marked decrease in subjective daytime sleepiness. This improvement was further associated with improvements in the propensity to fall asleep and nighttime sleep quality. Bright light therapy also affected depressive symptoms. "Our preliminary data suggests that morning bright light therapy might be helpful to reduce subjective daytime ...

No need to battle with cattle

2013-05-31

A new study by the Wildlife Conservation Society's Animal & Human Health for the Environment And Development (AHEAD) Program, World Wildlife Fund (WWF), and regional partners finds that a new approach to beef production in southern Africa could positively transform livelihoods for farmers and pastoralists, while helping to secure a future for wildlife and wildlife-based tourism opportunities. Market access for livestock and livestock products from Africa is constrained by the presence of foot and mouth disease (FMD). Fear of the FMD virus largely precludes large-scale ...

UCLA-led team may have found key to cause of Cushing disease

2013-05-31

FINDINGS: Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone (ACTH). The condition is marked by progressive weight gain, excessive fatty tissue deposits and a rounding of facial features, known as "moon face," and can lead to diabetes, hypertension, osteoporosis, obesity and psychological disturbances. Cushing disease, which is more common in women than men, is also associated with a three- to four-fold increase ...

Elevated carbon dioxide making arid regions greener

2013-05-31

WASHINGTON—Scientists have long suspected that a flourishing of green foliage around the globe, observed since the early 1980s in satellite data, springs at least in part from the increasing concentration of carbon dioxide in Earth's atmosphere. Now, a study of arid regions around the globe finds that a carbon dioxide "fertilization effect" has, indeed, caused a gradual greening from 1982 to 2010. Focusing on the southwestern corner of North America, Australia's outback, the Middle East, and some parts of Africa, Randall Donohue of the Commonwealth Scientific and Industrial ...

For first time atomic changes in a molecule during a chemical reaction photographed

2013-05-31

Taking an image of an individual molecule while it undergoes a chemical reaction has been deemed one of the holy grails of chemistry. Scientists at the University of Berkeley and the University of the Basque Country (UPV-EHU) have managed, for the very first time, to take direct, single-bond-resolved images of individual molecules just before and immediately after a complex organic reaction. The images enable appreciating the processes of the rupture and creation of links between the atoms making up a molecule. The article, entitled Direct Imaging of Covalent Bond Structure ...

The scoop on bird poop

2013-05-31

Gastrointestinal bacteria are important for digestion, immune functions and general health. Wouter van Dongen and colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna have collaborated with scientists from the Laboratoire Évolution & Diversité Biologique (EDB), Toulouse and from the US Geological Survey, Anchorage to study the cloacal bacterial assemblies of black-legged kittiwakes (Rissa tridactyla). The bacteria in the cloaca are known to be similar to assemblages deeper within the gastrointestinal tract, so the researchers examined samples ...